2/28/19: Closed 1/2 Position at 1.3 2/25/19: Added .93 1/7/19: Bought starter core position .63 Initial Target 1.3
High volume breakout in this rapidly growing cannabis investment firm and multi-state operator. 1/7/19: Bought starter core position .63 2/25/19: Added .93 Initial Target 1.3
In this interview, Dr. Russo shares an informed and insightful vision of how cannabis-derived medicine stands to benefit two of the more intractable neurological conditions facing older adults, Parkinson’s (PD) and Alzheimer’s (AD) diseases. Dr. Ethan Russo is a world-renowned authority on the medicinal use of cannabis; an academic researcher, author and industry leader whose … Read more Cannabis For Parkinson’s And Alzheimer’s Diseases
$EVIO has moved into previous congestion area and 200ma 2/21/19 Sold 1/2 position .76 2/6/19 Bot $EVIO .435. Initial target .58. $EVIO pick-and shovel play in the Lab/Testing verticle. All LP products must be tested before being sold.
$GTBIF breaking out from 3 month base. Short Term Target 18.9 Int. Term Target 22.3 $GTBIF part of $US MSO Basket, +29%YTD
Israeli Cannabis BioPharma (Parkinson’s). Drug delivery + Pain Management + Novel Technology Intec Pharma May Have a Blockbuster Parkinson’s Foundation Will Gather Experts to Study Cannabis as Disease Therapy 2/19/2019 News:
(click on image for video)
The last week clear rotation from Canadian LPs to US MSOs. CBD producers (ex: $CWBHF, $ELLXF) heavy due to FDS regulatory concerns. US MSOs stand to benefit the most from Banking Regulation changes .